Clinical Trial Update: A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors [Phase 1]

View source ↗

Summary

Clinical trial update on BMS-986488 evaluating its use as monotherapy and in combination therapy for advanced malignant tumors (Phase 1). The study is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• BMS-986488 (BMS-986488)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Advanced Malignant Tumors | Phase 1 | Status: ACTIVE_NOT_RECRUITING